Dietary Supplement Safety, Labeling Addressed In CFSAN Guidances
This article was originally published in The Tan Sheet
Executive Summary
CFSAN is seeking comments on the usefulness of tamper-evident packaging in helping minimize the risks of bioterrorist attacks on the food supply
You may also be interested in...
FDA Needs Greater Authority To Evaluate Structure/Function Claims – GAO
FDA should provide food firms with guidance on scientific support for structure/function claims, the Government Accountability Office recommends in a Jan. 14 report.
Bioterrorism Preparedness Addressed On Capitol Hill, At FDA
Any facility that manufactures, processes, packs or holds food for consumption in the U.S. would have to register with HHS within 180 days of the enactment of a bioterrorism bill passed by the House Dec. 12
Iron-containing products final rule includes revised warning language.
IRON-CONTAINING PRODUCTS WILL REQUIRE WARNINGS AND UNIT-DOSE PACKAGING under a final rule published by FDA in the Jan. 15 Federal Register. The rule specifies that all solid oral dosage forms of iron-containing drugs and dietary supplements must bear a warning concerning pediatric poisoning. In addition, products containing 30 mg of iron or more per dose must be sold in unit-dose packaging. The agency proposed the warning and packaging requirements Oct. 6, 1994 ("The Tan Sheet" Oct. 10, 1994, p. 3).